Showing results (171-180 of 393) with videos related to
Sort By:
Pageof 40
CJC Open|November 25, 2024
Centre-Specific Variation in Atrial Fibrillation Ablation-Treatment Rates in a Universal Single-Payer Healthcare SystemChristina Seo, Sameer Kushwaha, Paul Angaran, et al.JAMA Cardiology|May 19, 2021
Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc FactorsHusam Abdel-Qadir, Sheldon M Singh, Andrea Pang, et al.CJC Open|March 29, 2021
Detecting Patients With Nonvalvular Atrial Fibrillation and Atrial Flutter in the Canadian Primary Care Sentinel Surveillance Network: First StepsJohn A Queenan, Behrouz Ehsani-Moghaddam, Stephen B Wilton, et al.American Heart Journal|May 27, 2003
Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of lifeDavid M Newman, Paul Dorian, Miney Paquette, et al.The Canadian Journal of Cardiology|June 2, 2012
The burden of atrial fibrillation on the hospital sector in CanadaDaria J O'Reilly, Robert B Hopkins, Jeff S Healey, et al.Resuscitation|March 19, 2026
The impact of defibrillation current and pad position on return of spontaneous circulation during refractory ventricular fibrillationSheldon Cheskes, Ian R Drennan, Linda Turner, et al.European Heart Journal|September 29, 2012
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapyMichiel Coppens, John W Eikelboom, Robert G Hart, et al.Journal of Cardiovascular Electrophysiology|September 9, 2008
Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardiaGabriel Laurent, Howard Leong-Poi, Iqwal Mangat, et al.Clinical Therapeutics|February 11, 2014
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillationGregory Y H Lip, Thitima Kongnakorn, Hemant Phatak, et al.Resuscitation|February 19, 2020
High risk neighbourhoods: The effect of neighbourhood level factors on cardiac arrest incidenceKatherine S Allan, Joel G Ray, Peter Gozdyra, et al.Pageof 40